首页> 外国专利> Cancer monitoring by aberrant promotor methylation of the transcription factor genes PAX5 alpha PAX5 beta, novel loop helix loop protein, novel gene 2, and beta 3 genes

Cancer monitoring by aberrant promotor methylation of the transcription factor genes PAX5 alpha PAX5 beta, novel loop helix loop protein, novel gene 2, and beta 3 genes

机译:通过转录因子基因PAX5 alpha PAX5 beta,新型环螺旋环蛋白,新型基因2和beta 3基因的异常启动子甲基化来监测癌症

摘要

PAX5 alpha and PAX5 beta and other genes as markers for cancer detection. A PCR-based technique of methylated CpG island amplification, followed by representational difference analysis, for identifying genes methylated in human cancer. The genes PAX5 alpha and PAX5 beta, novel loop helix loop protein, and a novel gene 2, and beta3 genes when methylated serve as markers for detecting, monitoring, diagnosing and prognosticating breast, colon, and lung cancer in humans. Amplification methods, including primer sequences for methylation specific polymerase chain reaction, are disclosed.
机译:PAX5 alpha和PAX5 beta等基因可作为癌症检测的标记。基于PCR的甲基化CpG岛扩增技术,然后进行代表性差异分析,以鉴定人类癌症中甲基化的基因。当甲基化时,基因PAX5 alpha和PAX5 beta,新型环螺旋环蛋白以及新型基因2和beta3基因可作为检测,监测,诊断和预后人类乳腺癌,乳腺癌的标志物。公开了扩增方法,包括用于甲基化特异性聚合酶链反应的引物序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号